Wells Fargo & Company Intra Cellular Therapies, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 38,671 shares of ITCI stock, worth $3.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,671
Previous 40,861 5.36%
Holding current value
$3.31 Million
Previous $2.8 Million 1.04%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$67.99 - $80.84 $148,898 - $177,039
-2,190 Reduced 5.36%
38,671 $2.83 Million
Q2 2024

Aug 13, 2024
SELL
$64.76 - $79.84 $1.88 Million - $2.31 Million
-28,982 Reduced 41.5%
40,861 $2.8 Million
Q1 2024

May 10, 2024
BUY
$64.37 - $75.65 $681,549 - $800,982
10,588 Added 17.87%
69,843 $4.83 Million
Q4 2023

Feb 09, 2024
BUY
$46.37 - $73.65 $265,514 - $421,719
5,726 Added 10.7%
59,255 $4.24 Million
Q3 2023

Nov 13, 2023
SELL
$52.09 - $64.1 $785,517 - $966,627
-15,080 Reduced 21.98%
53,529 $2.79 Million
Q2 2023

Aug 15, 2023
BUY
$54.67 - $66.44 $1.15 Million - $1.39 Million
20,981 Added 44.05%
68,609 $4.34 Million
Q1 2023

May 12, 2023
BUY
$43.8 - $56.99 $770,661 - $1 Million
17,595 Added 58.59%
47,628 $2.58 Million
Q4 2022

Feb 13, 2023
SELL
$44.07 - $54.45 $106,384 - $131,442
-2,414 Reduced 7.44%
30,033 $1.59 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $25,064 - $35,214
-587 Reduced 1.78%
32,447 $1.51 Million
Q2 2022

Aug 12, 2022
SELL
$43.0 - $65.64 $448,060 - $683,968
-10,420 Reduced 23.98%
33,034 $1.89 Million
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $1.32 Million - $2.11 Million
-33,954 Reduced 43.86%
43,454 $2.66 Million
Q4 2021

Feb 14, 2022
BUY
$35.2 - $53.42 $636,416 - $965,833
18,080 Added 30.47%
77,408 $4.05 Million
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $128,263 - $189,760
4,466 Added 8.14%
59,328 $2.21 Million
Q2 2021

Aug 16, 2021
SELL
$29.3 - $44.5 $194,288 - $295,079
-6,631 Reduced 10.78%
54,862 $2.24 Million
Q1 2021

May 13, 2021
SELL
$30.8 - $39.51 $1.54 Million - $1.97 Million
-49,854 Reduced 44.77%
61,493 $2.09 Million
Q4 2020

Feb 09, 2021
BUY
$23.34 - $32.22 $629,316 - $868,747
26,963 Added 31.95%
111,347 $3.54 Million
Q3 2020

Nov 05, 2020
BUY
$17.61 - $31.86 $549,220 - $993,649
31,188 Added 58.63%
84,384 $2.17 Million
Q2 2020

Aug 13, 2020
BUY
$14.35 - $26.64 $330,494 - $613,545
23,031 Added 76.35%
53,196 $1.37 Million
Q1 2020

May 14, 2020
BUY
$12.31 - $33.12 $371,331 - $999,064
30,165 New
30,165 $464,000

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.08B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email